diffuse large b cell lymphoma trang 2 tải miễn phí từ TAILIEUCHUNG

"diffuse large b cell lymphoma" trang 2 - tải miễn phí từ Tailieuchung

Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma

Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma

8 58 0

Generalized crystal-storing histiocytosis with diffuse large B-cell lymphoma and monoclonal gammopathy in a Chinese elderly woman: A case report

Generalized crystal-storing histiocytosis with diffuse large B-cell lymphoma and monoclonal gammopathy in a Chinese elderly woman: A case report

8 84 0

Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count

Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count

10 85 0

An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

8 79 1

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

7 49 1

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma

7 39 1

Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: A single center experience

Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: A single center experience

8 21 1

Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma

Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma

12 60 1

Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement

Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement

7 27 1

$Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma$

Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma

7 44 1

$Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma$

Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

11 42 1

Network meta-analysis of targeted therapies for diffuse large B cell lymphoma

Network meta-analysis of targeted therapies for diffuse large B cell lymphoma

10 21 1

Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma

Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma

14 43 1

Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma

Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma

10 8 1

Application of CD54 in diagnosing bone marrow involvement by using flow cytometry in patients with diffuse large Bcell lymphoma

Application of CD54 in diagnosing bone marrow involvement by using flow cytometry in patients with diffuse large Bcell lymphoma

8 49 1

DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation

DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation

10 25 1

Clinical characteristics and prognostic factors of bone lymphomas: Focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas

Clinical characteristics and prognostic factors of bone lymphomas: Focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas

9 45 1

Fibrin-associated large B-cell lymphoma: First case report within a cerebral artery aneurysm and literature review

Fibrin-associated large B-cell lymphoma: First case report within a cerebral artery aneurysm and literature review

9 78 0

Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas

Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas

10 18 1

Clinical implications of SPRR1A expression in diffuse large B-cell lymphomas: A prospective, observational study

Clinical implications of SPRR1A expression in diffuse large B-cell lymphomas: A prospective, observational study

6 35 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.